Treatment of Multiple Sclerosis Using Over the Counter Inosine

NCT00067327 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: Inosine

Sponsor

National Center for Complementary and Integrative Health (NCCIH)